Alignment Healthcare’s (ALHC) “Sell (D-)” Rating Reiterated at Weiss Ratings

Weiss Ratings restated their sell (d-) rating on shares of Alignment Healthcare (NASDAQ:ALHC) in a research note released on Friday,Weiss Ratings reports.

A number of other research firms also recently commented on ALHC. The Goldman Sachs Group initiated coverage on Alignment Healthcare in a report on Tuesday, October 14th. They issued a “buy” rating and a $21.00 target price for the company. Wall Street Zen downgraded shares of Alignment Healthcare from a “buy” rating to a “hold” rating in a report on Sunday, August 10th. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a report on Monday, September 29th. KeyCorp raised Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 price target on the stock in a research note on Monday, August 25th. Finally, Barclays upgraded Alignment Healthcare from an “underweight” rating to an “equal weight” rating and upped their price target for the stock from $9.00 to $13.00 in a report on Thursday, July 31st. Two investment analysts have rated the stock with a Strong Buy rating, seven have assigned a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $19.05.

Alignment Healthcare Price Performance

Shares of ALHC opened at $17.51 on Friday. The company has a current ratio of 1.66, a quick ratio of 1.66 and a debt-to-equity ratio of 2.29. The stock’s 50 day moving average is $16.66 and its two-hundred day moving average is $15.56. Alignment Healthcare has a twelve month low of $10.18 and a twelve month high of $21.06. The firm has a market capitalization of $3.47 billion, a PE ratio of -62.53 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last issued its earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business had revenue of $1.02 billion during the quarter, compared to the consensus estimate of $960.25 million. During the same period in the prior year, the business posted ($0.13) EPS. The company’s revenue for the quarter was up 49.0% on a year-over-year basis. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. Research analysts anticipate that Alignment Healthcare will post -0.69 earnings per share for the current year.

Insider Buying and Selling at Alignment Healthcare

In other Alignment Healthcare news, CEO John E. Kao sold 355,018 shares of the firm’s stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total transaction of $5,825,845.38. Following the completion of the transaction, the chief executive officer owned 4,533,568 shares of the company’s stock, valued at approximately $74,395,850.88. This trade represents a 7.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Christopher J. Joyce sold 30,939 shares of the business’s stock in a transaction on Wednesday, September 10th. The stock was sold at an average price of $16.41, for a total value of $507,708.99. Following the completion of the transaction, the insider directly owned 343,592 shares of the company’s stock, valued at approximately $5,638,344.72. This trade represents a 8.26% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 7,443,207 shares of company stock worth $119,848,080. 6.60% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Several institutional investors have recently added to or reduced their stakes in ALHC. State of Alaska Department of Revenue purchased a new position in Alignment Healthcare in the 3rd quarter valued at about $186,000. SG Americas Securities LLC acquired a new position in shares of Alignment Healthcare in the third quarter valued at approximately $424,000. KLP Kapitalforvaltning AS lifted its stake in shares of Alignment Healthcare by 20.4% during the third quarter. KLP Kapitalforvaltning AS now owns 28,900 shares of the company’s stock valued at $504,000 after buying an additional 4,900 shares during the period. Simplify Asset Management Inc. lifted its stake in shares of Alignment Healthcare by 13.8% during the third quarter. Simplify Asset Management Inc. now owns 136,934 shares of the company’s stock valued at $2,389,000 after buying an additional 16,613 shares during the period. Finally, CWM LLC grew its stake in Alignment Healthcare by 349.0% in the 3rd quarter. CWM LLC now owns 39,511 shares of the company’s stock worth $689,000 after acquiring an additional 30,711 shares during the period. Institutional investors and hedge funds own 86.19% of the company’s stock.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.